It was a family with three affected members (father, son, daughter) carrying an identical germline frameshift mutation p.P23Rfs*137 in the N-terminal of CEBPA. The three patients in the pedigree developed AML at the age of 10, 18, and 30 years, respectively. The gene discussed is CEBPA; the disease is acute myeloid leukemia.